Molecular therapy for bone cancer: Testosterone inhibits the expression of histone demethylase KDM3A (JMJD1A/JHDM2A) via induction of its target gene, 25/December/2013, 7.53 am

Novel Insights into Mineralization and Skeletogenes: 1α,25-dihydroxy vitamin D(3) increases the expression of BMPR2 via down regulation of its target gene, 25/December/2013, 7.47 am
December 25, 2013
Molecular therapy for bone cancer: 1α,25-dihydroxy vitamin D(3) inhibits the expression of histone demethylase KDM3A (JMJD1A/JHDM2A) via up regulation of its target gene, 25/December/2013, 7.59 am
December 25, 2013
Show all

Idea Proposed byDr L Boominathan Ph.D.

Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/

To citeBoominathan, Molecular therapy for bone cancer: Testosterone inhibits the expression of histone demethylase KDM3A (JMJD1A/JHDM2A) via induction of its target gene, 25/December/2013, 7.53 am,Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org

* Research cooperation

Comments are closed.